Agah Ramtin (CIK 1862617) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-22). Recent activity: Buy RNXT (10,000 shares), Buy RNXT (9,795 shares), Buy RNXT (205 shares), Buy RNXT (12,000 shares), Buy RNXT (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 10,000 | $10,000 |
| 2026-01-05 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 9,795 | $8,424 |
| 2026-01-02 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 205 | $170 |
| 2025-12-17 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 12,000 | $10,200 |
| 2025-12-08 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 10,000 | $9,600 |
| 2025-11-24 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 10,000 | $8,000 |
| 2025-11-24 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 12,000 | $9,600 |
| 2025-06-09 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 21,000 | $29,400 |
| 2025-06-06 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Sell | 400,000 | $0 |
| 2025-04-17 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 15,000 | $13,500 |
| 2025-04-14 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 20,000 | $16,000 |
| 2025-04-10 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 30,000 | $24,300 |
| 2025-04-09 | RenovoRx, Inc. (RNXT) | Chief Medical Officer | Buy | 26,000 | $21,840 |
Source: SEC Form 4 filings · as of 2026-01-22